Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Vaccine Effectiveness × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2392 Neoplasms 1830 Carcinoma, Non-Small-Cell Lung 1580 Prostatic Neoplasms 1285 Colorectal Neoplasms 1098 Lung Neoplasms 968 Neoplasm Metastasis 831 Multiple Myeloma 788 Leukemia, Myeloid, Acute 777 Ovarian Neoplasms 679 Pancreatic Neoplasms 674 Melanoma 664 Squamous Cell Carcinoma of Head and Neck 588 Recurrence 575 Carcinoma, Hepatocellular 565 Brain Neoplasms 520 Stomach Neoplasms 507 Glioblastoma 503 Head and Neck Neoplasms 490 Triple Negative Breast Neoplasms 471 Lymphoma 458 Uterine Cervical Neoplasms 450 Precursor Cell Lymphoblastic Leukemia-Lymphoma 423 Carcinoma, Renal Cell 423 Lymphoma, Non-Hodgkin 395 Endometrial Neoplasms 382 Sarcoma 363 Hematologic Neoplasms 359 Lymphoma, Large B-Cell, Diffuse 354 Urinary Bladder Neoplasms 351

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡